MedPath

Effect of high-dose oral Acetyl-L-carnitine versus placebo on serum level of oxidative and nirtosative stress and clinical outcomes in patients with ischemic stroke

Phase 2
Conditions
ischemic stroke.
Cerebral infarction
Registration Number
IRCT20150629022965N17
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

18 to 85 years old
Ischemic stroke Stroke for the first time
Local neurologic disorder
Patients who have been admitted for the first 24 hours after the stroke

Exclusion Criteria

Pregnancy or breastfeeding
Inflammatory disease
Asthma
History of anaphylaxis shock

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath